Selected research
Market Analysis & Forecast
Global AI-Powered Clinical Decision Support Market Analysis and Forecast 2026-2032
Market perspective
The global AI-Powered Clinical Decision Support market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for AI-Powered Clinical Decision Support is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for AI-Powered Clinical Decision Support is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for AI-Powered Clinical Decision Support is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for AI-Powered Clinical Decision Support is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of AI-Powered Clinical Decision Support include IBM, Zebra Medical Vision, Medtronic, Aidoc, Cerner, Tempus Labs, Philips, CloudMedx and Allscripts, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for AI-Powered Clinical Decision Support, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of AI-Powered Clinical Decision Support, also provides the revenue of main regions and countries. Of the upcoming market potential for AI-Powered Clinical Decision Support, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the AI-Powered Clinical Decision Support revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI-Powered Clinical Decision Support market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI-Powered Clinical Decision Support revenue, projected growth trends, production technology, application and end-user industry.
AI-Powered Clinical Decision Support Segment by Company
IBM
Zebra Medical Vision
Medtronic
Aidoc
Cerner
Tempus Labs
Philips
CloudMedx
Allscripts
McKesson
Siemens Healthineers
Qventus
Epic Systems
Verily Life Sciences
AI-Powered Clinical Decision Support Segment by Type
Standalone CDS Systems
Integrated CDS Systems
AI-Powered Clinical Decision Support Segment by Application
Hospital
Clinic
Others
AI-Powered Clinical Decision Support Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Powered Clinical Decision Support market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-Powered Clinical Decision Support and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Powered Clinical Decision Support.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of AI-Powered Clinical Decision Support in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of AI-Powered Clinical Decision Support company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-Powered Clinical Decision Support revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Standalone CDS Systems
- Integrated CDS Systems
Applications
- Hospital
- Clinic
- Others
Companies covered
- IBM
- Zebra Medical Vision
- Medtronic
- Aidoc
- Cerner
- Tempus Labs
- Philips
- CloudMedx
- Allscripts
- McKesson
- Siemens Healthineers
- Qventus
- Epic Systems
- Verily Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 AI-Powered Clinical Decision Support Market by Type
- 1.2.1 Global AI-Powered Clinical Decision Support Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Standalone CDS Systems
- 1.2.3 Integrated CDS Systems
- 1.3 AI-Powered Clinical Decision Support Market by Application
- 1.3.1 Global AI-Powered Clinical Decision Support Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI-Powered Clinical Decision Support Market Dynamics
- 2.1 AI-Powered Clinical Decision Support Industry Trends
- 2.2 AI-Powered Clinical Decision Support Industry Drivers
- 2.3 AI-Powered Clinical Decision Support Industry Opportunities and Challenges
- 2.4 AI-Powered Clinical Decision Support Industry Restraints
3 Global Growth Perspective
- 3.1 Global AI-Powered Clinical Decision Support Market Perspective (2021-2032)
- 3.2 Global AI-Powered Clinical Decision Support Growth Trends by Region
- 3.2.1 Global AI-Powered Clinical Decision Support Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global AI-Powered Clinical Decision Support Market Size by Region (2021-2026)
- 3.2.3 Global AI-Powered Clinical Decision Support Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global AI-Powered Clinical Decision Support Revenue by Players
- 4.1.1 Global AI-Powered Clinical Decision Support Revenue by Players (2021-2026)
- 4.1.2 Global AI-Powered Clinical Decision Support Revenue Market Share by Players (2021-2026)
- 4.1.3 Global AI-Powered Clinical Decision Support Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global AI-Powered Clinical Decision Support Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global AI-Powered Clinical Decision Support Key Players Headquarters & Area Served
- 4.4 Global AI-Powered Clinical Decision Support Players, Product Type & Application
- 4.5 Global AI-Powered Clinical Decision Support Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global AI-Powered Clinical Decision Support Market CR5 and HHI
- 4.6.3 2025 AI-Powered Clinical Decision Support Tier 1, Tier 2, and Tier 3
5 AI-Powered Clinical Decision Support Market Size by Type
- 5.1 Global AI-Powered Clinical Decision Support Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global AI-Powered Clinical Decision Support Revenue by Type (2021-2032)
- 5.3 Global AI-Powered Clinical Decision Support Revenue Market Share by Type (2021-2032)
6 AI-Powered Clinical Decision Support Market Size by Application
- 6.1 Global AI-Powered Clinical Decision Support Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global AI-Powered Clinical Decision Support Revenue by Application (2021-2032)
- 6.3 Global AI-Powered Clinical Decision Support Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 IBM
- 7.1.1 IBM Company Information
- 7.1.2 IBM Business Overview
- 7.1.3 IBM AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.1.4 IBM AI-Powered Clinical Decision Support Product Portfolio
- 7.1.5 IBM Recent Developments
- 7.2 Zebra Medical Vision
- 7.2.1 Zebra Medical Vision Company Information
- 7.2.2 Zebra Medical Vision Business Overview
- 7.2.3 Zebra Medical Vision AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.2.4 Zebra Medical Vision AI-Powered Clinical Decision Support Product Portfolio
- 7.2.5 Zebra Medical Vision Recent Developments
- 7.3 Medtronic
- 7.3.1 Medtronic Company Information
- 7.3.2 Medtronic Business Overview
- 7.3.3 Medtronic AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.3.4 Medtronic AI-Powered Clinical Decision Support Product Portfolio
- 7.3.5 Medtronic Recent Developments
- 7.4 Aidoc
- 7.4.1 Aidoc Company Information
- 7.4.2 Aidoc Business Overview
- 7.4.3 Aidoc AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.4.4 Aidoc AI-Powered Clinical Decision Support Product Portfolio
- 7.4.5 Aidoc Recent Developments
- 7.5 Cerner
- 7.5.1 Cerner Company Information
- 7.5.2 Cerner Business Overview
- 7.5.3 Cerner AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.5.4 Cerner AI-Powered Clinical Decision Support Product Portfolio
- 7.5.5 Cerner Recent Developments
- 7.6 Tempus Labs
- 7.6.1 Tempus Labs Company Information
- 7.6.2 Tempus Labs Business Overview
- 7.6.3 Tempus Labs AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.6.4 Tempus Labs AI-Powered Clinical Decision Support Product Portfolio
- 7.6.5 Tempus Labs Recent Developments
- 7.7 Philips
- 7.7.1 Philips Company Information
- 7.7.2 Philips Business Overview
- 7.7.3 Philips AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.7.4 Philips AI-Powered Clinical Decision Support Product Portfolio
- 7.7.5 Philips Recent Developments
- 7.8 CloudMedx
- 7.8.1 CloudMedx Company Information
- 7.8.2 CloudMedx Business Overview
- 7.8.3 CloudMedx AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.8.4 CloudMedx AI-Powered Clinical Decision Support Product Portfolio
- 7.8.5 CloudMedx Recent Developments
- 7.9 Allscripts
- 7.9.1 Allscripts Company Information
- 7.9.2 Allscripts Business Overview
- 7.9.3 Allscripts AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.9.4 Allscripts AI-Powered Clinical Decision Support Product Portfolio
- 7.9.5 Allscripts Recent Developments
- 7.10 McKesson
- 7.10.1 McKesson Company Information
- 7.10.2 McKesson Business Overview
- 7.10.3 McKesson AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.10.4 McKesson AI-Powered Clinical Decision Support Product Portfolio
- 7.10.5 McKesson Recent Developments
- 7.11 Siemens Healthineers
- 7.11.1 Siemens Healthineers Company Information
- 7.11.2 Siemens Healthineers Business Overview
- 7.11.3 Siemens Healthineers AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.11.4 Siemens Healthineers AI-Powered Clinical Decision Support Product Portfolio
- 7.11.5 Siemens Healthineers Recent Developments
- 7.12 Qventus
- 7.12.1 Qventus Company Information
- 7.12.2 Qventus Business Overview
- 7.12.3 Qventus AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.12.4 Qventus AI-Powered Clinical Decision Support Product Portfolio
- 7.12.5 Qventus Recent Developments
- 7.13 Epic Systems
- 7.13.1 Epic Systems Company Information
- 7.13.2 Epic Systems Business Overview
- 7.13.3 Epic Systems AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.13.4 Epic Systems AI-Powered Clinical Decision Support Product Portfolio
- 7.13.5 Epic Systems Recent Developments
- 7.14 Verily Life Sciences
- 7.14.1 Verily Life Sciences Company Information
- 7.14.2 Verily Life Sciences Business Overview
- 7.14.3 Verily Life Sciences AI-Powered Clinical Decision Support Revenue and Gross Margin (2021-2026)
- 7.14.4 Verily Life Sciences AI-Powered Clinical Decision Support Product Portfolio
- 7.14.5 Verily Life Sciences Recent Developments
8 North America
- 8.1 North America AI-Powered Clinical Decision Support Revenue (2021-2032)
- 8.2 North America AI-Powered Clinical Decision Support Revenue by Type (2021-2032)
- 8.2.1 North America AI-Powered Clinical Decision Support Revenue by Type (2021-2026)
- 8.2.2 North America AI-Powered Clinical Decision Support Revenue by Type (2027-2032)
- 8.3 North America AI-Powered Clinical Decision Support Revenue Share by Type (2021-2032)
- 8.4 North America AI-Powered Clinical Decision Support Revenue by Application (2021-2032)
- 8.4.1 North America AI-Powered Clinical Decision Support Revenue by Application (2021-2026)
- 8.4.2 North America AI-Powered Clinical Decision Support Revenue by Application (2027-2032)
- 8.5 North America AI-Powered Clinical Decision Support Revenue Share by Application (2021-2032)
- 8.6 North America AI-Powered Clinical Decision Support Revenue by Country
- 8.6.1 North America AI-Powered Clinical Decision Support Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America AI-Powered Clinical Decision Support Revenue by Country (2021-2026)
- 8.6.3 North America AI-Powered Clinical Decision Support Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe AI-Powered Clinical Decision Support Revenue (2021-2032)
- 9.2 Europe AI-Powered Clinical Decision Support Revenue by Type (2021-2032)
- 9.2.1 Europe AI-Powered Clinical Decision Support Revenue by Type (2021-2026)
- 9.2.2 Europe AI-Powered Clinical Decision Support Revenue by Type (2027-2032)
- 9.3 Europe AI-Powered Clinical Decision Support Revenue Share by Type (2021-2032)
- 9.4 Europe AI-Powered Clinical Decision Support Revenue by Application (2021-2032)
- 9.4.1 Europe AI-Powered Clinical Decision Support Revenue by Application (2021-2026)
- 9.4.2 Europe AI-Powered Clinical Decision Support Revenue by Application (2027-2032)
- 9.5 Europe AI-Powered Clinical Decision Support Revenue Share by Application (2021-2032)
- 9.6 Europe AI-Powered Clinical Decision Support Revenue by Country
- 9.6.1 Europe AI-Powered Clinical Decision Support Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe AI-Powered Clinical Decision Support Revenue by Country (2021-2026)
- 9.6.3 Europe AI-Powered Clinical Decision Support Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China AI-Powered Clinical Decision Support Revenue (2021-2032)
- 10.2 China AI-Powered Clinical Decision Support Revenue by Type (2021-2032)
- 10.2.1 China AI-Powered Clinical Decision Support Revenue by Type (2021-2026)
- 10.2.2 China AI-Powered Clinical Decision Support Revenue by Type (2027-2032)
- 10.3 China AI-Powered Clinical Decision Support Revenue Share by Type (2021-2032)
- 10.4 China AI-Powered Clinical Decision Support Revenue by Application (2021-2032)
- 10.4.1 China AI-Powered Clinical Decision Support Revenue by Application (2021-2026)
- 10.4.2 China AI-Powered Clinical Decision Support Revenue by Application (2027-2032)
- 10.5 China AI-Powered Clinical Decision Support Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia AI-Powered Clinical Decision Support Revenue (2021-2032)
- 11.2 Asia AI-Powered Clinical Decision Support Revenue by Type (2021-2032)
- 11.2.1 Asia AI-Powered Clinical Decision Support Revenue by Type (2021-2026)
- 11.2.2 Asia AI-Powered Clinical Decision Support Revenue by Type (2027-2032)
- 11.3 Asia AI-Powered Clinical Decision Support Revenue Share by Type (2021-2032)
- 11.4 Asia AI-Powered Clinical Decision Support Revenue by Application (2021-2032)
- 11.4.1 Asia AI-Powered Clinical Decision Support Revenue by Application (2021-2026)
- 11.4.2 Asia AI-Powered Clinical Decision Support Revenue by Application (2027-2032)
- 11.5 Asia AI-Powered Clinical Decision Support Revenue Share by Application (2021-2032)
- 11.6 Asia AI-Powered Clinical Decision Support Revenue by Country
- 11.6.1 Asia AI-Powered Clinical Decision Support Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia AI-Powered Clinical Decision Support Revenue by Country (2021-2026)
- 11.6.3 Asia AI-Powered Clinical Decision Support Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA AI-Powered Clinical Decision Support Revenue (2021-2032)
- 12.2 SAMEA AI-Powered Clinical Decision Support Revenue by Type (2021-2032)
- 12.2.1 SAMEA AI-Powered Clinical Decision Support Revenue by Type (2021-2026)
- 12.2.2 SAMEA AI-Powered Clinical Decision Support Revenue by Type (2027-2032)
- 12.3 SAMEA AI-Powered Clinical Decision Support Revenue Share by Type (2021-2032)
- 12.4 SAMEA AI-Powered Clinical Decision Support Revenue by Application (2021-2032)
- 12.4.1 SAMEA AI-Powered Clinical Decision Support Revenue by Application (2021-2026)
- 12.4.2 SAMEA AI-Powered Clinical Decision Support Revenue by Application (2027-2032)
- 12.5 SAMEA AI-Powered Clinical Decision Support Revenue Share by Application (2021-2032)
- 12.6 SAMEA AI-Powered Clinical Decision Support Revenue by Country
- 12.6.1 SAMEA AI-Powered Clinical Decision Support Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA AI-Powered Clinical Decision Support Revenue by Country (2021-2026)
- 12.6.3 SAMEA AI-Powered Clinical Decision Support Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst